Actimus Biosciences Private Limited - Company Profile

It is a life sciences private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2004.
2004 Visakhapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Actimus Biosciences Private Limited

Actimus Biosciences Private Limited, a active private limited company, was established on 28 January 2004 in Visakhapatnam, Andhra Pradesh, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U74140AP2004PTC042512. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.50 Cr.

Formerly known as Tavisa Biosciences Private Limited. It upholds a compliant status. Employing 273 professional, Its leadership includes Devadi Srinivasa Rao (Director), Ajjagottu Ramanathareddy (Managing Director), Devadi Shiva Kumar (Director). Past directors included Devadi Srinivasa Rao, Srinivas Reddy Maram, Parthasaradhi Reddy Ajjagottu. It holds ₹28.38 Cr open charges and ₹5.35 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 4Th Floor, Varun Towers,7-8-1/3, Kasturigba Marg, Siripuram,, Visakhapatnam, Andhra Pradesh, 530003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74140AP2004PTC042512

  • Registration Number

    042512

  • Incorporation Date

    28 January 2004

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.50 Cr

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.50 Cr
  • Company Age 22 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 28.38 Cr
  • Satisfied Charges ₹ 5.35 Cr
  • Revenue Growth **** 32.08%
  • Profit Growth **** 128.17%
  • Ebitda **** 64.02%
  • Net Worth 31.46%
  • Total Assets **** 23.05%
Company report

Actimus Biosciences Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Actimus Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Actimus Biosciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Devadi Srinivasa Rao Director 26 Mar 2013 Current
Ajjagottu Ramanathareddy Managing Director 28 Jan 2004 Current
Devadi Shiva Kumar Director 26 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Feb 2022 Past
Pramod Abcsdd Director 27 Mar 2013 Past
Pramod Abcsdd Director 31 Dec 2011 Past
Pramod Abcsdd Director 31 Mar 2010 Past
Pramod Abcsdd Director 31 Mar 2010 Past
Pramod Abcsdd Director 31 Mar 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Actimus Biosciences.

Actimus Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.08% increase. The company also saw a substantial improvement in profitability, with a 128.17% increase in profit. The company's net worth Soared by an impressive increase of 31.46%.

Actimus Biosciences revenue growth over time
Actimus Biosciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 32.08%
*******
*******
*******
*******
Revenue from Operations
*******
 35.02%
*******
*******
*******
*******
Total Assets
*******
 23.05%
*******
*******
*******
*******
Profit or Loss
*******
 128.17%
*******
*******
*******
*******
Net Worth
*******
 31.46%
*******
*******
*******
*******
EBITDA
*******
 64.02%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Actimus Biosciences?

In 2023, Actimus Biosciences had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹283,750,000.00

Satisfied Charges

₹53,500,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 28.38 Cr
Latest Charge Details
Date Lender Amount Status
30 May 2025 Hdfc Bank Limited ₹28.38 Cr Open
01 Oct 2015 Canara Bank ₹3.50 Cr Satisfied
16 Apr 2011 State Bank Of India ₹8.50 M Satisfied
18 Nov 2008 State Bank Of India ₹1.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Actimus Biosciences?

Actimus Biosciences has a workforce of 273 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Actimus Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Actimus Biosciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Actimus Biosciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Actimus Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Devadi Shiva Kumar was appointed as a Director was appointed as a Director on 26 Jul 2025 & has been associated with this company since 9 months 16 days . was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 28.38 Cr with Charge ID 101106404 was registered on 30 May 2025. was recorded as a recent event.

  • Balance Sheet

    Actimus Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 01 Oct 2015 via Charge ID 100029051 with Canara Bank was fully satisfied on 03 Jul 2023. was documented.

  • Charges

    A charge registered on 16 Apr 2011 via Charge ID 10288052 with State Bank Of India was fully satisfied on 18 Jan 2017. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Actimus Biosciences Private Limited?

The CIN of Actimus Biosciences Private Limited is U74140AP2004PTC042512.

Where is Actimus Biosciences Private Limited headquartered?

Actimus Biosciences Private Limited is headquartered at 4Th Floor, Varun Towers,7-8-1/3, Kasturigba Marg, Siripuram,, Visakhapatnam, Andhra Pradesh, 530003.

When was Actimus Biosciences Private Limited incorporated?

Actimus Biosciences Private Limited was incorporated on 28 January 2004.

Who are the current directors of Actimus Biosciences Private Limited?

The current directors of Actimus Biosciences Private Limited are

What is the primary industry of Actimus Biosciences Private Limited?

The primary industry of Actimus Biosciences Private Limited is Professional, Scientific And Technical.

Is Actimus Biosciences Private Limited a listed company?

Actimus Biosciences Private Limited is unlisted.

What is the capital structure of Actimus Biosciences Private Limited?

The authorized capital of Actimus Biosciences Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.50 Cr.

What is the compliance status of Actimus Biosciences Private Limited?

The compliance status of Actimus Biosciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available